// App-Quantinova.ai

TMOD-27 : EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA

Researchers

Presenter

  • David Ashley

Principal Investigators

  • Stephen T Keir

  • Martin A Roskoski

  • Rhian Davies

  • Ben Williams

  • Stephen J P Damment

  • Kelly Conlon

Medical Centers

  • Midatech Pharma PLC, Cardiff, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Glioblastoma

  • Acro–dermato–ungual–lacrimal–tooth (ADULT) syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Panobinostat

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved